These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 314442)

  • 41. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
    García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J
    J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escherichia coli ATCC 35218 as a quality control isolate for susceptibility testing of Haemophilus influenzae with haemophilus test medium.
    Butler DL; Jakielaszek CJ; Miller LA; Poupard JA
    Antimicrob Agents Chemother; 1999 Feb; 43(2):283-6. PubMed ID: 9925519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
    Goldstein FW; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1979 Nov; 5(6):705-9. PubMed ID: 395156
    [No Abstract]   [Full Text] [Related]  

  • 47. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
    Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
    Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility of Haemophilus influenzae isolates collected from 4 centers in Brazil (1990-2003).
    de Almeida AE; de Filippis I; Ferreira DG; de Abreu AO; Rebelo C; Gemal AL; Marzochi KB
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):57-62. PubMed ID: 16290031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High frequency of β-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae in patients with chronic bronchitis in Japan.
    Inoue S; Watanuki Y; Miyazawa N; Kudo M; Sato T; Kobayashi N; Mishina K; Sasaki M; Kaneko T; Ishigatsubo Y
    J Infect Chemother; 2010 Feb; 16(1):72-5. PubMed ID: 20082107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single report of β-lactam resistance in an invasive Haemophilus influenzae isolate from South Africa mediated by mutations in penicillin-binding protein 3, 2003-2008.
    Fali A; du Plessis M; Wolter N; Klugman KP; von Gottberg A
    Int J Antimicrob Agents; 2010 Nov; 36(5):480-2. PubMed ID: 20846827
    [No Abstract]   [Full Text] [Related]  

  • 52. Emergence and prevalence of beta-lactamase producing Haemophilus influenzae in Finland and susceptibility of 102 respiratory isolates to eight antibiotics.
    Jokipii L; Jokipii AM
    J Antimicrob Chemother; 1980 Sep; 6(5):623-31. PubMed ID: 6967871
    [No Abstract]   [Full Text] [Related]  

  • 53. High nasopharyngeal carriage of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae in north Indian school-going children.
    Jain A; Kumar P; Agarwal SK
    J Infect Chemother; 2008 Feb; 14(1):72-4. PubMed ID: 18297455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results of a multicenter study of antibiotic sensitivity].
    Dabernat H
    Pathol Biol (Paris); 1983 Feb; 31(2):77-9. PubMed ID: 6341948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial susceptibility of respiratory Haemophilus influenzae strains isolated from pediatric respiratory tract infections.
    Cao LD; Naruhiko I; Nobue T; Yoichi K
    Pediatr Int; 2004 Aug; 46(4):419-24. PubMed ID: 15310306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of cloned inhibitor-resistant TEM beta-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate.
    Tristram SG; Burdach JG
    J Antimicrob Chemother; 2007 Nov; 60(5):1151-4. PubMed ID: 17827143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Oteo J; Campos J
    J Antimicrob Chemother; 2013 Jan; 68(1):159-63. PubMed ID: 23034712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced.
    Hasegawa K; Kobayashi R; Takada E; Ono A; Chiba N; Morozumi M; Iwata S; Sunakawa K; Ubukata K;
    J Antimicrob Chemother; 2006 Jun; 57(6):1077-82. PubMed ID: 16617062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.